Core Insights - CARBIOS has suspended its liquidity contract with Natixis ODDO BHF as of January 19, 2026, due to satisfactory liquidity of its shares [2][3]. - As of December 31, 2025, the liquidity account held 12,989 shares and €198,347.09 [2]. - The liquidity contract was established in accordance with the French Financial Market Authority's regulations [3]. Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions for plastics and textiles, aiming to prevent pollution and promote a circular economy [4]. - The company has two main technologies: PET biorecycling and PLA biodegradation, which are being scaled to industrial levels [4]. - CARBIOS collaborates with major brands in various industries, including Nestlé Waters, PepsiCo, and L'Oréal, to enhance product recyclability [4]. Trading Activity - During the semester, there were 3,209 buy-side executions totaling 509,491 shares traded for €4,740,354.18, while sell-side executions totaled 3,538 for 512,000 shares at €4,738,838.30 [6]. - The liquidity account showed a consistent trading volume, indicating active market participation [6].

Core Viewpoint - CARBIOS is committed to advancing the construction of its Longlaville plant, with a revised timeline and significant pre-commercialization contracts in place to support its financing efforts [2][8]. Financing and Project Timeline - A small portion of the financing is still required, with the goal to secure it by the end of Q1 2026, allowing for the plant to be commissioned in the first half of 2028 [5][8]. - The project has secured public funding of €42.5 million and is expected to be financially independent from CARBIOS through non-recourse financing [4][8]. - CARBIOS anticipates having over €55 million in available cash by the end of 2025, providing visibility on its financing horizon for the next twelve months [8]. Commercialization and Market Engagement - In 2025, CARBIOS signed pre-commercialization contracts covering nearly 50% of the production capacity at the Longlaville site, with aims to increase this to 70% soon [3][8]. - The company is actively pursuing commercialization of its technology licenses, having established a strategic partnership with Wankai New Materials for deployment in Asia, and plans to expand into Europe and the Americas [6][12]. Technological and Environmental Commitment - CARBIOS focuses on developing biological solutions for plastic and textile lifecycle management, utilizing enzyme-based processes for PET biorecycling and PLA biodegradation [7]. - The company collaborates with major brands in the cosmetics, food, and apparel sectors to enhance product recyclability and support a circular economy [7].

据了解，CARBIOS是法国最具创新力的材料科技企业之一，其开发的生物酶法PET解聚技术被认为是"塑料循环领域的革命性突破"，被 纳入"France2030"法国2030国家战略重点项目，获得法国政府及全球消费品行业的高度关注。 12月3日，万凯新材（301216）与法国生物科技先锋CARBIOS在浙江海宁正式签署合作协议，宣布共同建设全球首台套、年产5万吨的生 物酶解聚PET再生工业化装置，该项目暂定总投资1.15亿欧元(约9.22亿元)。万凯新材表示，该合作标志着生物酶法PET解聚技术首次在亚 洲规模化落地。 签约仪式上，海宁市委、市政府主要领导、法国CARBIOS全球管理团队、万凯新材高管，以及马石油、米其林、诺和新元、H&M、农夫 山泉、吉利集团、Tims咖啡等多家国际品牌方、投资机构、行业协会共同出席。 生物酶法技术走向工业化 公告显示，为推动消费后PET再生循环产业化落地，确立在再生PET领域的竞争领先地位，万凯新材与Carbios S.A.签署了《股东协议》， 双方将在中国成立一家合资公司，其中万凯新材占比70%。双方将通过合资公司合作建设首座年处理5万吨废料的生物酶解聚PET再生项 目以及运营 ...

France-based CARBIOS and China’s Wankai New Materials, a listed subsidiary of Zhink Group, have agreed to form a joint venture (JV) partnership for the industrial rollout of CARBIOS’ polyethylene terephthalate (PET) biorecycling technology in Asia. The partnership will start with a new facility in China. Following the signing yesterday (2 December), the two companies have sealed a shareholders’ agreement to create a JV that will construct and operate what is described as the debut PET biorecycling plant ...

Core Points - CARBIOS and Wankai New Materials have established a strategic partnership for the large-scale deployment of CARBIOS's PET biorecycling technology in Asia, starting with a PET biorecycling plant in China [1][2][3] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, aiming to prevent plastic pollution and promote a circular economy [2][3] - The company has two main technologies: PET biorecycling and PLA biodegradation, with an operational industrial demonstration plant since 2021 [2] Partnership Details - The joint venture will construct a PET biorecycling plant in Haining, Zhejiang province, with a processing capacity of 50,000 tons of PET waste [3] - Wankai will hold a 70% stake in the joint venture, while CARBIOS will retain 30% [3] - The estimated construction cost of the plant is €115 million, financed by 30% equity and 70% debt, with all debt guaranteed by Wankai [3] Future Plans - Construction of the plant is expected to begin in Q1 2026, with commissioning targeted for Q1 2027 [3] - CARBIOS has committed to exclusively license its PET depolymerization technology in Asia to Wankai for three years, with potential extensions based on additional capacity agreements [3] Financial Commitment - Wankai will subscribe to a capital increase of €5 million in CARBIOS S.A. before June 2, 2026, at a share price of €8.0947, reflecting a 10% discount [3]

Core Points - CARBIOS and Wankai New Materials have established a strategic partnership for the large-scale deployment of CARBIOS's PET biorecycling technology in Asia, starting with a PET biorecycling plant in China [1][2][3] - The joint venture will have a processing capacity of 50,000 tons of PET waste, with Wankai holding a 70% stake and CARBIOS holding 30% [3] - The construction of the plant is estimated to cost €115 million, financed by 30% equity and 70% debt, with all debt guaranteed by Wankai [3] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, aiming to prevent plastic pollution and promote a circular economy [2] - The company has two main technologies: PET biorecycling and PLA biodegradation, with its industrial demonstration plant for biorecycling operational since 2021 [2] - CARBIOS collaborates with major brands in various industries to enhance the recyclability of their products and is part of the global community of B Corp™ certified companies [2] Partnership Details - The shareholders' agreement for the joint venture was signed on December 2, 2025, with construction expected to begin in Q1 2026 and commissioning targeted for Q1 2027 [3] - CARBIOS will exclusively license its PET depolymerization technology to Wankai for three years, with potential extensions based on additional capacity agreements [3] - Wankai has committed to a €5 million capital increase in CARBIOS S.A. before June 2, 2026, at a share price of €8.0947, reflecting a 10% discount [3]

Core Insights - CARBIOS has signed two new multi-year commercial agreements with major players in the beverage industry for the supply of recycled PET (r-PET) [1][7] - These agreements validate CARBIOS's technology and support its strategy of sector diversification [2][7] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, aiming to prevent pollution and promote a circular economy [3] - The company has two main technologies: one for PET biorecycling and another for PLA biodegradation, both of which are scaling up to industrial levels [3] - CARBIOS's industrial demonstration plant for biorecycling has been operational since 2021, with plans to resume construction of the world's first biorecycling plant by the end of 2025, pending additional funding [3] Strategic Developments - The new commercial agreements are part of the pre-commercialization process for CARBIOS's future industrial site, achieving approximately 50% of the site's maximum production capacity in pre-sales [7] - Ongoing negotiations aim to reach a pre-commercialization level of 70%, which is crucial for securing additional non-dilutive funding necessary for the Longlaville plant's construction [7] - A regional grant of €12.5 million has been secured, increasing the total public funding to €42.5 million [7]

Core Viewpoint - CARBIOS and Wankai New Materials have signed a collaboration agreement to implement CARBIOS's enzymatic PET recycling technology in Asia, marking a significant strategic advancement for both companies in establishing a circular PET industry in the region [1][5][6]. Group 1: Agreement Details - The agreement includes the construction and operation of multiple PET biorecycling plants in Asia, with a total capacity of up to 1 million tons per year [2][8]. - The first step involves establishing a joint venture to build a PET biorecycling plant in China, with an annual processing capacity of 50,000 tons of PET waste [3][8]. - Wankai will guarantee the financing of the joint venture and become the main shareholder, with construction expected to begin in Q1 2026 [3][4]. Group 2: Investment and Licensing - Wankai will invest €5 million in CARBIOS to strengthen the strategic partnership [4]. - CARBIOS will grant an exclusive license for its technology to the joint venture, marking the first licensing of its technology and confirming the viability of its business model [5][6]. Group 3: Market Context - China, as the world's leading PET producer, is a crucial market for CARBIOS, and this agreement is a significant step towards a sustainable PET industry in Asia [5][6]. - The partnership aims to contribute to a circular and low-carbon PET industry, aligning with global sustainability goals [6].

Core Points - CARBIOS and Wankai New Materials have signed an agreement to collaborate on deploying CARBIOS' PET enzymatic recycling technology in Asia, marking a significant step in the development of a circular PET industry in the region [1][6][8] Group 1: Agreement Details - The agreement establishes a long-term commitment to build and operate several PET biorecycling plants in Asia, targeting a total capacity of one million tonnes per year [2][8] - The first joint venture will focus on constructing a PET biorecycling plant in China with an annual processing capacity of 50,000 tonnes of PET waste [3][8] - Wankai will be the main shareholder of the joint venture, which will be financed by Wankai, and is expected to start construction in the first quarter of 2026 [4][8] Group 2: Financial Aspects - Wankai will invest €5 million in CARBIOS S.A. to strengthen the strategic partnership [4] - The finalization of the partnership, including the shareholders' agreement and license agreement, is expected by the end of 2025 [5][8] Group 3: Strategic Importance - China, as the world's leading producer of PET, is a crucial market for CARBIOS, and this agreement is seen as a strategic advancement for both companies [6][8] - The collaboration aims to accelerate the transition to a more circular and low-carbon PET industry [7][8]

Core Points - CARBIOS and Wankai New Materials have signed a fundamental agreement to collaborate on deploying CARBIOS' enzymatic PET recycling technology in Asia [1][2] - The partnership aims to build and operate multiple biorecycling plants in Asia with a target capacity of 1 million tons per year [2][9] - The first step involves creating a joint venture to construct and operate a biorecycling plant in China with an annual capacity of 50,000 tons of PET waste [3][9] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, utilizing enzyme-based processes for plastic deconstruction [8] - The company has been operational since 2021 with its industrial demonstration plant for biorecycling and plans to commence construction of the world's first biorecycling plant by the end of 2025, pending additional funding [8] - CARBIOS is supported by prestigious brands in the cosmetic, food, and apparel industries to enhance the recyclability and circularity of their products [8][10] Investment and Financial Aspects - Wankai will be the majority shareholder of the joint venture and will guarantee the financing for the first biorecycling plant, with an investment of €5 million in CARBIOS' capital [4][5] - The partnership remains subject to the finalization of definitive agreements, including a shareholders' pact and a licensing contract, with the goal of signing by the end of the year [5][9] Strategic Importance - The agreement marks a strategic step for both CARBIOS and Wankai, aiming to accelerate the development of a circular PET industry in Asia, which is a key market for CARBIOS as the world's largest PET producer [6][7] - This collaboration is seen as a significant milestone in the international deployment of CARBIOS' technology and its licensing model [7]